LP228747-4
JAK2 gene exon 12 targeted mutation analysis
Active
Description
Mutations in the Janus kinase 2 (JAK2) gene exon 12 are present in significant numbers of patients with myeloproliferative neoplasias (MPNs). MPNs are distinguished by having clones of malignant cells that are derived from an unrestricted proliferation of hematopoietic progenitors. In patients with MPN, excessive numbers of mature and functional blood cells are produced. Mutations that interfere with the signaling of protein tyrosine kinase are also thought to play a role in MPNs. PMID: 19074595 Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- JAK2 gene exon 12 targeted mutation analysis
- Part Display Name
- JAK2 gene exon 12 targeted mutation analysis
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-09-13
- Construct for LOINC Short Name
- JAK2 gene exon 12 targeted mutation analysis
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP228747-4
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| fr-CA | French (Canada) | JAK2 exon 12 gène ciblé, analyse de la mutation |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://